Search Results - Vikas Kundra
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
Diffusion weighted imaging in prostate cancer by Cher Heng Tan, Jihong Wang, Vikas Kundra
Published 2010Revisão -
2
-
3
Diffusion-Weighted MRI in the Detection of Prostate Cancer: Meta-Analysis by Cher Heng Tan, Wei Wei, Valen E. Johnson, Vikas Kundra
Published 2012Revisão -
4
-
5
Stress-inducible, Murine Protein mSTI1 by Michael Lässle, Gregory L. Blatch, Vikas Kundra, Toshiro Takatori, Bruce R. Zetter
Published 1997Artigo -
6
Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction... by Baharak Bahmani, Yadir Guerrero, Danielle Bacon, Vikas Kundra, Valentine I. Vullev, Bahman Anvari
Published 2014Artigo -
7
-
8
-
9
-
10
-
11
-
12
-
13
Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts by Edmond J. Auzenne, Sukhen C. Ghosh, Mojgan Khodadadian, Belinda Rivera, David Farquhar, Roger E. Price, Murali K. Ravoori, Vikas Kundra, Ralph S. Freedman, Jim Klostergaard
Published 2007Artigo -
14
Whole-body MRI in pediatric patients with cancer by Marcos Duarte Guimarães, Julia Noschang, Sara Reis Teixeira, Marcel Koenigkam Santos, Henrique Manoel Lederman, Vivian Siqueira Tostes, Vikas Kundra, Alex Dias de Oliveira, Bruno Hochhegger, Edson Marchiori
Published 2017Revisão -
15
PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway by Yong Pan, Patrea R. Rhea, Lin Tan, Carrie Cartwright, Ho-Jeong Lee, Murali K. Ravoori, Crandell Addington, Mihai Gagea, Vikas Kundra, Sun-Jin Kim, Robert A. Newman, Peiying Yang
Published 2014Artigo -
16
A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic Activity by Joseph R. Garlich, Pradip De, Nandini Dey, Jing Su, Xiaodong Peng, Antoinette Miller, Ravoori Murali, Yiling Lu, Gordon B. Mills, Vikas Kundra, H-K. Shu, Qiong Peng, Donald L. Durden
Published 2008Artigo -
17
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages by Barbara Visentin, John A. Vekich, Bradley J. Sibbald, Amy L. Cavalli, Kelli Moreno, Rosalía Matteo, William Garland, Yiling Lu, Shuangxing Yu, Hassan Hall, Vikas Kundra, Gordon B. Mills, Roger A. Sabbadini
Published 2006Artigo -
18
Pharmacodynamic Markers of Perifosine Efficacy by Bryan T. Hennessy, Yiling Lu, Enrique Poradosu, Qianghua Yu, Shuangxing Yu, Hassan Hall, Mark Carey, Murali K. Ravoori, Ana M. González-Angulo, Robert Birch, I. Craig Henderson, Vikas Kundra, Gordon B. Mills
Published 2007Artigo -
19
Phase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer by Robert L. Coleman, Linda Duska, Pedro T. Ramírez, John V. Heymach, Aparna A. Kamat, Susan C. Modesitt, Kathleen M. Schmeler, Revathy B. Iyer, Michael Garcia, Debbie Miller, Edward F. Jackson, Chaan S. Ng, Vikas Kundra, Robert B. Jaffe, Anil K. Sood
Published 2011Artigo -
20
Antitumor and Antivascular Effects of AVE8062 in Ovarian Carcinoma by Tae Jin Kim, Murali K. Ravoori, Charles N. Landen, Aparna A. Kamat, Liz Y. Han, Chunhua Lü, Yvonne G. Lin, William M. Merritt, Nicholas Jennings, Whitney A. Spannuth, Robert R. Langley, David M. Gershenson, Robert L. Coleman, Vikas Kundra, Anil K. Sood
Published 2007Artigo
Search Tools:
Related Subjects
Medicine
Cancer
Internal medicine
Biology
Cancer research
Biochemistry
Cell biology
Pharmacology
Prostate cancer
Radiology
Chemistry
Chemotherapy
Magnetic resonance imaging
Pathology
Prostate
Angiogenesis
Apoptosis
Biotechnology
In vivo
Oncology
Physics
Receptor
Endocrinology
Gene
Genetics
Metastasis
Nuclear medicine
Ovarian cancer
PI3K/AKT/mTOR pathway
Pharmacokinetics